HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Expiration Date Rationale Requested By Waxman

This article was originally published in The Tan Sheet

Executive Summary

Data on FDA's expiration date policies and safety/ effectiveness standards for OTC and Rx drugs are requested by Rep. Henry Waxman (D-Calif.) in a May 19 letter to FDA.

You may also be interested in...

Drug Shelf Life Effect On Cost Uncertain, AMA Report Finds

Additional research is needed to determine whether longer drug product shelf lives would lower drug costs, the American Medical Association Council on Scientific Affairs says in a report prepared for the AMA House of Delegates meeting in Chicago June 17-21.

Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001

Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.

Waxman/Hatch Debate Moves Forward: CHPA Aims To Protect OTC Exclusivity

Preservation of the three-year exclusivity awarded for clinical studies supporting Rx-to-OTC switches under the existing Waxman/Hatch Act is the Consumer Healthcare Products Association's top priority as patent reform discussions take shape on Capitol Hill.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts